Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Phosphorylation Stabilized TET1 Acts As an Oncoprotein and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia

Blood (2022) 140 (Supplement 1): 998–1000.

https://doi.org/10.1182/blood-2022-165469

Published: 2022

Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137555

Published: 2020

Journal Articles

DNMT3A wt NPM1-Mutation Defines a Subgroup of MDS with Special Favorable Outcomes Towards Decitabine Therapy

Lingyun Wu, MD PhD, Xiao Li, MD, Feng Xu, He Qi, Zheng Zhang, Dong Wu, Luxi Song, MD, Liyu Zhou, Chao Xiao, Jiying Su, Juan Guo, Chunkang Chang

Blood (2019) 134 (Supplement_1): 1724.

https://doi.org/10.1182/blood-2019-124008

Published: 2019

Journal Articles

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Qian Xu, Zheng Zhang, MD, Lei Zhao, MD, Yun Qin, Yicheng Zhang, MD PhD, Jue Wang, MD PhD, Jianfeng Zhou, MD PhD

Blood (2018) 132 (Supplement 1): 3487.

https://doi.org/10.1182/blood-2018-99-115003

Published: 2018

Journal Articles

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Jinsheng Weng, MD PhD, Kelsey Moriarty, BD, Yong Pan, Man Chun John MA, PhD, Rohit Mathur, PhD, Zheng Zhang, Hiroki Torikai, MD, Sourindra N Maiti, Fuliang Chu, PhD, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J N Cooper, MD PhD, R. Eric Davis, MD, Sattva S. Neelapu, MD

Blood (2018) 132 (Supplement 1): 3488.

https://doi.org/10.1182/blood-2018-99-115424

Published: 2018

Journal Articles

B-Cell Maturation Antigen (BCMA)-Specific, Centyrin TM -Based, PiggyBac TM -Transposed CAR-T Memory Stem Cells Are Effective Against p53 -/- and Patient-Derived Multiple Myeloma Tumors

Blood (2017) 130 (Supplement 1): 3068.

https://doi.org/10.1182/blood.V130.Suppl_1.3068.3068

Published: 2017

Journal Articles

Universal SLAMF7-Specific CAR T-Cells As Treatment for Multiple Myeloma

Rohit Mathur, PhD, Zheng Zhang, Jin He, Roman Galetto, PhD, Agnès Gouble, PhD, Isabelle Chion-Sotinel, Stéphanie Filipe, PhD, Annabelle Gariboldi, Tanooha Veeramachaneni, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Hans C. Lee, MD, Krina K. Patel, MDMSc, Donna M. Weber, MD, R. Eric Davis, MD, Robert J. Orlowski, MD PhD, Julianne Smith, PhD, Jing Yang, PhD, Sattva S. Neelapu, MD

Blood (2017) 130 (Supplement 1): 502.

https://doi.org/10.1182/blood.V130.Suppl_1.502.502

Published: 2017

Journal Articles

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Youshan Zhao, Dong Wu, Chengming Fei, Juan Guo, Shucheng Gu, Feng Xu, Zheng Zhang, Chunkang Chang, Xiao Li, MD PhD

Blood (2014) 124 (21): 4365.

https://doi.org/10.1182/blood.V124.21.4365.4365

Published: 2014

Journal Articles

Clinical Observation Of Decitabine Treatment In Selected Patients With Lower Risk Myelodysplastic Syndromes

Chunkang Chang, Zheng Zhang, Youshan Zhao, Xiao Li, MD, PhD

Blood (2013) 122 (21): 5202.

https://doi.org/10.1182/blood.V122.21.5202.5202

Published: 2013

Journal Articles

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Xiao Li, MD, PhD, Chunkang Chang, Qi He, Feng Xu, Qingxia Zhang, Lingyun Wu, Jiying Su, Xi Zhang, Liyu Zhou, Dong Wu, Zheng Zhang

Blood (2013) 122 (21): 1575.

https://doi.org/10.1182/blood.V122.21.1575.1575

Published: 2013

Journal Articles

Efficacy and Toxicity Of Decitabine Versus CHG Priming Regimen In Patients With Higher Risk Myelodysplastic Syndrome

Lingyun Wu, Xiao Li, MD, PhD, Feng Xu, Chunkang Chang, Qi He, Zheng Zhang, Luxi Song, Xi Zhang, Jiying Su, Liyu Zhou

Blood (2013) 122 (21): 2789.

https://doi.org/10.1182/blood.V122.21.2789.2789

Published: 2013

Journal Articles

A 15 Mg/M 2 /d Dose of Decitabine Confers Comparable Responses and Better Tolerance Than the Standard Regimen in MDS patients—results of a Multicenter Prospective Cohort Study

Xiao Li, MD, PhD, Qiang Song, MD, Yu Chen, Chunkang Chang, Dong Wu, Lingyun Wu, Jiying Su, Luxi Song, Zheng Zhang, Feng Xu, Ming Hou

Blood (2012) 120 (21): 3832.

https://doi.org/10.1182/blood.V120.21.3832.3832

Published: 2012

Journal Articles

Combined Low-Dose Homoharringtonine, Cytarabine and Granulocyte Colony-Stimulating Factor for Patients with Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Transformed From MDS

Lingyun Wu, Xiao Li, MD, PhD, Chunkang Chang, Jiying Shu, Li Xu, Zheng Zhang

Blood (2010) 116 (21): 4004.

https://doi.org/10.1182/blood.V116.21.4004.4004

Published: 2010

Journal Articles

Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.

Qi He, Xiao Li, MD, PhD, Zheng Zhang, Qingqiao Zhang, Feng Xu, Lianping Yang, Ying Tao, Yizhi Liu

Blood (2009) 114 (22): 4832.

https://doi.org/10.1182/blood.V114.22.4832.4832

Published: 2009

Journal Articles

Removal of Autologous Activated CD4 Positive T Lymphocytes Also Result in Increased Colony-Forming Units (CFUs) in Patients with Myelodysplastic Syndromes.

Zheng Zhang, Xiao Li, MD, PhD, Qingqiao Zhang, Qi He, Feng Xu, Lingyun Wu, MD

Blood (2009) 114 (22): 4862.

https://doi.org/10.1182/blood.V114.22.4862.4862

Published: 2009

Journal Articles

In Vitro Deprivation of CD8 + CD57 + t Cells Promotes the Malignant Growth of Bone Marrow Stem/Progenitor Cells in Patients with Myelodysplastic Syndrome.

Qianqiao Zhang, Xiao Li, MD, PhD, Zheng Zhang, Feng Xu, Qi He, Lingyun Wu, MD, Chunkang Chang

Blood (2009) 114 (22): 1764.

https://doi.org/10.1182/blood.V114.22.1764.1764

Published: 2009

Journal Articles

Depleting Autologous Activated CD4 + t Lymphocytes Increased Generation of Colony-Forming-Cells(CFC) in Patients with Myelodysplastic Syndromes

Zheng Zhang, Xiao Li, MD, PhD, Qianqiao Zhang, Ying Tao, Qi He

Blood (2008) 112 (11): 5092.

https://doi.org/10.1182/blood.V112.11.5092.5092

Published: 2008

Journal Articles

Human Leukocyte Antigen DR15 in Patients with Myelodysplastic Syndromes (MDS) – A Study in Chinese Patients.

Qiong Liao Master, Yan Zhang, Xiao Li, PhD, MD, Zheng Zhang, Shaoxu Ying, Ph.D., M.D., Chunkang Chang Master, Quan Pu, M.D., (Intr. by H. Joachim Deeg)

Blood (2007) 110 (11): 2463.

https://doi.org/10.1182/blood.V110.11.2463.2463

Published: 2007

Journal Articles

PD-1 up-regulation is correlated with HIV-specific memory CD8 + T-cell exhaustion in typical progressors but not in long-term nonprogressors

Ji-Yuan Zhang, Zheng Zhang, Xicheng Wang, Jun-Liang Fu, Jinxia Yao, Yanmei Jiao, Liangen Chen, Hui Zhang, Jianan Wei, Lei Jin, Ming Shi, George Fu Gao, Hao Wu, Fu-Sheng Wang

Blood (2007) 109 (11): 4671–4678.

https://doi.org/10.1182/blood-2006-09-044826

Published: 2007

Journal Articles

Expression of a non–DNA-binding isoform of Helios induces T-cell lymphoma in mice

Zheng Zhang, C. Scott Swindle, John T. Bates, Rose Ko, Claudiu V. Cotta, Christopher A. Klug

Blood (2006) 109 (5): 2190–2197.

https://doi.org/10.1182/blood-2005-01-031930

Published: 2006

NARROW

Phosphorylation Stabilized TET1 Acts As an Oncoprotein and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

DNMT3A wt NPM1-Mutation Defines a Subgroup of MDS with Special Favorable Outcomes Towards Decitabine Therapy

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

B-Cell Maturation Antigen (BCMA)-Specific, Centyrin TM -Based, PiggyBac TM -Transposed CAR-T Memory Stem Cells Are Effective Against p53 -/- and Patient-Derived Multiple Myeloma Tumors

Universal SLAMF7-Specific CAR T-Cells As Treatment for Multiple Myeloma

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Clinical Observation Of Decitabine Treatment In Selected Patients With Lower Risk Myelodysplastic Syndromes

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Efficacy and Toxicity Of Decitabine Versus CHG Priming Regimen In Patients With Higher Risk Myelodysplastic Syndrome

A 15 Mg/M 2 /d Dose of Decitabine Confers Comparable Responses and Better Tolerance Than the Standard Regimen in MDS patients—results of a Multicenter Prospective Cohort Study

Combined Low-Dose Homoharringtonine, Cytarabine and Granulocyte Colony-Stimulating Factor for Patients with Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Transformed From MDS

Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.

Removal of Autologous Activated CD4 Positive T Lymphocytes Also Result in Increased Colony-Forming Units (CFUs) in Patients with Myelodysplastic Syndromes.

In Vitro Deprivation of CD8 + CD57 + t Cells Promotes the Malignant Growth of Bone Marrow Stem/Progenitor Cells in Patients with Myelodysplastic Syndrome.

Depleting Autologous Activated CD4 + t Lymphocytes Increased Generation of Colony-Forming-Cells(CFC) in Patients with Myelodysplastic Syndromes

Human Leukocyte Antigen DR15 in Patients with Myelodysplastic Syndromes (MDS) – A Study in Chinese Patients.

PD-1 up-regulation is correlated with HIV-specific memory CD8 + T-cell exhaustion in typical progressors but not in long-term nonprogressors

Expression of a non–DNA-binding isoform of Helios induces T-cell lymphoma in mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only